Suzan Koussa

发表

Beta-thalassemia: the Lebanese experience.

A. Inati, A. Taher, H. Isma'eel, 2006, Clinical and laboratory haematology.

Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial

R. Mahfouz, S. Azar, A. Inati, 2006, Annals of Hematology.

Levels of non‐transferrin‐bound iron as an index of iron overload in patients with thalassaemia intermedia

M. Cappellini, A. Inati, A. Taher, 2009, British journal of haematology.

Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia

M. Cappellini, A. Inati, A. Taher, 2008, Haematologica.

Sickle cell disease: new insights into pathophysiology and treatment.

A. Inati, A. Taher, S. Perrine, 2008, Pediatric annals.

Identification of the First Mutation in a Bre Motif of the β-Globin Gene and its Inheritance with two Other α-Globin Gene Mutations in a Lebanese Family

A. Inati, D. Chui, Hong‐yuan Luo, 2013, Hemoglobin.

Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy

A. Inati, A. Taher, K. Musallam, 2009, Annals of Hematology.

Febrile Neutropenia and Hemorrhagic Stroke in a Thalassemia Major Patient

A. Inati, A. Taher, M. Sheikh-Taha, 2007, Hemoglobin.

Safety and Effectiveness of 100 mg/kg/day Deferiprone in Patients with Thalassemia Major: A Two-Year Study

A. Dhillon, A. Inati, A. Taher, 2005, Acta Haematologica.